0001572565 false 2021 Q3 --12-31 Yes P0Y
0001572565 2021-01-01 2021-09-30 0001572565 2021-09-30 0001572565
2020-12-31 0001572565 INQD:SeriesAConvertiblePreferredStockMember
2021-09-30 0001572565 INQD:SeriesAConvertiblePreferredStockMember
2020-12-31 0001572565 2021-07-01 2021-09-30 0001572565 2020-07-01
2020-09-30 0001572565 2020-01-01 2020-09-30 0001572565
INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2020-12-31 0001572565
us-gaap:CommonStockMember 2020-12-31 0001572565
us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001572565
INQD:StockPayableMember 2020-12-31 0001572565
us-gaap:RetainedEarningsMember 2020-12-31 0001572565
INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001572565
us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001572565
us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31
0001572565 INQD:StockPayableMember 2021-01-01 2021-03-31 0001572565
us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001572565
2021-01-01 2021-03-31 0001572565
INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2021-03-31 0001572565
us-gaap:CommonStockMember 2021-03-31 0001572565
us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001572565
INQD:StockPayableMember 2021-03-31 0001572565
us-gaap:RetainedEarningsMember 2021-03-31 0001572565 2021-03-31
0001572565 INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001572565
us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001572565
us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30
0001572565 INQD:StockPayableMember 2021-04-01 2021-06-30 0001572565
us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001572565
2021-04-01 2021-06-30 0001572565
INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2021-06-30 0001572565
us-gaap:CommonStockMember 2021-06-30 0001572565
us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001572565
INQD:StockPayableMember 2021-06-30 0001572565
us-gaap:RetainedEarningsMember 2021-06-30 0001572565 2021-06-30
0001572565 INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001572565
us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001572565
us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30
0001572565 INQD:StockPayableMember 2021-07-01 2021-09-30 0001572565
us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001572565
INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2021-09-30 0001572565
us-gaap:CommonStockMember 2021-09-30 0001572565
us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001572565
INQD:StockPayableMember 2021-09-30 0001572565
us-gaap:RetainedEarningsMember 2021-09-30 0001572565
INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2019-12-31 0001572565
us-gaap:CommonStockMember 2019-12-31 0001572565
us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001572565
INQD:StockPayableMember 2019-12-31 0001572565
us-gaap:RetainedEarningsMember 2019-12-31 0001572565 2019-12-31
0001572565 INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2020-01-01 2020-03-31 0001572565
us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001572565
us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31
0001572565 INQD:StockPayableMember 2020-01-01 2020-03-31 0001572565
us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001572565
2020-01-01 2020-03-31 0001572565
INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2020-03-31 0001572565
us-gaap:CommonStockMember 2020-03-31 0001572565
us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001572565
INQD:StockPayableMember 2020-03-31 0001572565
us-gaap:RetainedEarningsMember 2020-03-31 0001572565 2020-03-31
0001572565 INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2020-04-01 2020-06-30 0001572565
us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001572565
us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30
0001572565 INQD:StockPayableMember 2020-04-01 2020-06-30 0001572565
us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001572565
2020-04-01 2020-06-30 0001572565
INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2020-06-30 0001572565
us-gaap:CommonStockMember 2020-06-30 0001572565
us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001572565
INQD:StockPayableMember 2020-06-30 0001572565
us-gaap:RetainedEarningsMember 2020-06-30 0001572565 2020-06-30
0001572565 INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2020-07-01 2020-09-30 0001572565
us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001572565
us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30
0001572565 INQD:StockPayableMember 2020-07-01 2020-09-30 0001572565
us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001572565
INQD:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember 2020-09-30 0001572565
us-gaap:CommonStockMember 2020-09-30 0001572565
us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001572565
INQD:StockPayableMember 2020-09-30 0001572565
us-gaap:RetainedEarningsMember 2020-09-30 0001572565 2020-09-30
0001572565 us-gaap:FairValueInputsLevel1Member 2021-09-30
0001572565 us-gaap:FairValueInputsLevel2Member 2021-09-30
0001572565 us-gaap:FairValueInputsLevel3Member 2021-09-30
0001572565 us-gaap:FairValueInputsLevel1Member 2020-12-31
0001572565 us-gaap:FairValueInputsLevel2Member 2020-12-31
0001572565 us-gaap:FairValueInputsLevel3Member 2020-12-31
0001572565 INQD:NoteOneMember 2021-09-30 0001572565
INQD:NoteOneMember 2020-12-31 0001572565 INQD:NoteTwoMember
2021-09-30 0001572565 INQD:NoteTwoMember 2020-12-31 0001572565
INQD:NoteThreeMember 2021-09-30 0001572565 INQD:NoteThreeMember
2020-12-31 0001572565 INQD:NoteFourMember 2021-09-30 0001572565
INQD:NoteFourMember 2020-12-31 0001572565 INQD:NoteFiveMember
2021-09-30 0001572565 INQD:NoteFiveMember 2020-12-31 0001572565
us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-09-30
0001572565 us-gaap:ConvertibleNotesPayableMember 2020-01-01
2020-09-30 0001572565 INQD:InvestmentAgreementMember
INQD:TangiersGlobalLLCMember
INQD:FixedConvertiblePromissoryNoteMember 2017-10-12 0001572565
INQD:InvestmentAgreementMember INQD:TangiersGlobalLLCMember
INQD:FixedConvertiblePromissoryNoteMember 2017-10-11 2017-10-12
0001572565 INQD:InvestmentAgreementMember
INQD:TangiersGlobalLLCMember
INQD:FixedConvertiblePromissoryNoteMember 2021-01-01 2021-09-30
0001572565
INQD:TenPercentageFixedConvertiblePromissoryNoteTwoMember
INQD:PowerUpLendingGroupLtdMember 2019-10-22 0001572565
INQD:TenPercentageFixedConvertiblePromissoryNoteTwoMember
INQD:PowerUpLendingGroupLtdMember 2019-10-21 2019-10-22 0001572565
INQD:TenPercentageFixedConvertiblePromissoryNoteThreeMember
INQD:PowerUpLendingGroupLtdMember 2019-12-19 0001572565
INQD:TenPercentageFixedConvertiblePromissoryNoteThreeMember
INQD:PowerUpLendingGroupLtdMember 2019-12-18 2019-12-19 0001572565
INQD:TenPercentageFixedConvertiblePromissoryNoteFourMember
INQD:RelatedPartyMember 2020-09-28 0001572565
INQD:TenPercentageFixedConvertiblePromissoryNoteFourMember
INQD:RelatedPartyMember 2020-09-27 2020-09-28 0001572565
INQD:ThirdPartyMember 2021-03-01 2021-03-31 0001572565
INQD:TenPercentageFixedConvertiblePromissoryNoteFiveMember
2021-08-09 0001572565
INQD:TenPercentageFixedConvertiblePromissoryNoteFiveMember
2021-08-08 2021-08-09 0001572565 srt:MaximumMember 2021-01-01
2021-09-30 0001572565 srt:MinimumMember 2021-01-01 2021-09-30
0001572565 us-gaap:MeasurementInputPriceVolatilityMember
srt:MinimumMember 2021-09-30 0001572565
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember 2021-09-30 0001572565
us-gaap:MeasurementInputExpectedDividendRateMember 2021-09-30
0001572565 us-gaap:MeasurementInputRiskFreeInterestRateMember
2021-09-30 0001572565 INQD:SeriesAConvertiblePreferredStockMember
2021-09-30 0001572565 INQD:SeriesAConvertiblePreferredStockMember
2020-12-31 0001572565 INQD:SeriesAConvertiblePreferredStockMember
INQD:ModificationAgreementMember 2021-08-25 2021-08-27 0001572565
INQD:SubscriptionAgreementMember us-gaap:CommonStockMember
2021-08-24 2021-08-26 0001572565 INQD:SubscriptionAgreementMember
us-gaap:CommonStockMember 2021-08-26 0001572565 2021-08-02
2021-08-04 0001572565 INQD:LeslieBocskorMember 2021-08-02
2021-08-04 0001572565 INQD:BenjaminRoteMember 2021-08-02 2021-08-04
0001572565 INQD:DennisForchicMember 2021-08-02 2021-08-04
0001572565 INQD:LeslieBocskorMember 2021-01-01 2021-09-30
0001572565 INQD:BenjaminRoteMember 2021-01-01 2021-09-30 0001572565
INQD:DennisForchicMember 2021-01-01 2021-09-30 0001572565
srt:BoardOfDirectorsChairmanMember 2021-01-01 2021-09-30 0001572565
us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-01-01
2021-09-30 0001572565 us-gaap:SubsequentEventMember
us-gaap:ConvertibleNotesPayableMember 2021-10-01 2021-10-02
0001572565 us-gaap:SubsequentEventMember us-gaap:CommonStockMember
us-gaap:SeriesAPreferredStockMember 2021-11-08 0001572565
INQD:SubscriptionAgreementMember us-gaap:CommonStockMember
us-gaap:SubsequentEventMember 2021-11-06 2021-11-08 0001572565
INQD:SubscriptionAgreementMember us-gaap:CommonStockMember
us-gaap:SubsequentEventMember 2021-11-08 0001572565
us-gaap:SubsequentEventMember
INQD:TenPercentFixedConvertiblePromissoryNoteMember 2021-11-09
0001572565 us-gaap:SubsequentEventMember
INQD:TenPercentFixedConvertiblePromissoryNoteMember 2021-11-07
2021-11-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
INQD:Days xbrli:pure
UNITED
STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form
10-Q
(Mark
One)
☒ |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 |
For the
quarterly period ended |
September 30, 2021 |
|
or
☐ |
TRANSITION REPORT UNDER
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934 |
For the
transition period from |
|
to |
|
|
Commission
File Number |
000-55594 |
|
INDOOR HARVEST CORP |
(Exact name
of registrant as specified in its charter) |
Texas |
|
45-5577364 |
(State or
other jurisdiction
of
incorporation or organization)
|
|
(IRS
Employer
Identification
No.)
|
7401 W. Slaughter Lane #5078
Austin,
Texas
|
|
78739 |
(Address of
principal executive offices) |
|
(Zip
Code) |
512-309-1776 |
(Registrant’s telephone
number, including area code) |
N/A |
(Former
name, former address and former fiscal year, if changed since last
report) |
Securities
registered pursuant to Section 12(b) of the Act:
Title of
each class |
|
Trading
Symbol(s) |
|
Name of each
exchange on which registered |
|
|
|
|
|
Indicate by
check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for
the past 90 days.
☒
YES ☐
NO
Indicate by
check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (Section 232.405 of this chapter) during
the preceding 12 months (or for such shorter period that the
registrant was required to submit such files).
Yes ☒ No ☐
Indicate by
check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, smaller reporting
company, or an emerging growth company. See the definitions of
“large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the
Exchange Act.
Large accelerated
filer |
☐ |
Accelerated
filer |
☐ |
Non-accelerated filer |
☐ |
(Do not
check if a smaller reporting company) |
Smaller
reporting company |
☒ |
|
|
|
Emerging growth
company |
☒ |
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
Indicate by
check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act)
☐ YES ☒
NO
Indicate the
number of shares outstanding of each of the issuer’s classes of
common stock, as of the latest practicable date:
2,483,396,041 common shares issued and outstanding as of
September 30, 2021.
TABLE OF
CONTENTS
FORWARD-LOOKING
STATEMENTS
Except for
any historical information contained herein, the matters discussed
in this quarterly report on Form 10-Q contain certain
“forward-looking statements’’ within the meaning of the federal
securities laws. This includes statements regarding our future
financial position, economic performance, results of operations,
business strategy, budgets, projected costs, plans and objectives
of management for future operations, and the information referred
to under “Management’s Discussion and Analysis of Financial
Condition and Results of Operations.”
These
forward-looking statements generally can be identified by the use
of forward-looking terminology, such as “may,” “will,” “expect,”
“intend,” “estimate,” “anticipate,” “believe,” “continue” or
similar terminology, although not all forward-looking statements
contain these words. These forward-looking statements are not
historical facts, and are based on current expectations, estimates
and projections about our industry, management’s beliefs and
certain assumptions made by management, many of which, by their
nature, are inherently uncertain and beyond our control.
Accordingly, you are cautioned that any such forward-looking
statements are not guarantees of future performance and are subject
to certain risks, uncertainties and assumptions that are difficult
to predict. Although we believe that the expectations reflected in
such forward-looking statements are reasonable as of the date made,
expectations may prove to have been materially different from the
results expressed or implied by such forward-looking statements.
Important factors that may cause actual results to differ from
projections include, for example:
|
● |
the success
or failure of management’s efforts to implement our business
plan; |
|
● |
our ability
to fund our operating expenses; |
|
● |
our ability
to compete with other companies that have a similar business
plan; |
|
● |
the effect
of changing economic conditions impacting our plan of operation;
and |
|
● |
our ability
to meet the other risks as may be described in future filings with
the Securities and Exchange Commission (the “SEC”). |
Unless
otherwise required by law, we also disclaim any obligation to
update our view of any such risks or uncertainties or to announce
publicly the result of any revisions to the forward-looking
statements made in this quarterly report on Form 10-Q.
When
considering these forward-looking statements, you should keep in
mind the cautionary statements in this quarterly report on Form
10-Q and in our other filings with the SEC. We cannot assure you
that the forward-looking statements in this quarterly report on
Form 10-Q will prove to be accurate. Furthermore, if our
forward-looking statements prove to be inaccurate, the inaccuracy
may prove to be material. In light of the significant uncertainties
in these forward-looking statements, you should not regard these
statements as a representation or warranty by us or any other
person that we will achieve our objectives and plans in any
specified time-frame, or at all.
PART I - FINANCIAL
INFORMATION
Item
1. |
Financial
Statements |
INDOOR
HARVEST CORP
CONDENSED
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
The
accompanying notes are an integral part of these unaudited
consolidated financial statements.
INDOOR
HARVEST CORP
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
The
accompanying notes are an integral part of these unaudited
consolidated financial statements.
INDOOR
HARVEST CORP
CONDENSED
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
(UNAUDITED)
For
the Nine months Ended September 30, 2021
For
the Nine months Ended September 30, 2020
|
|
Number of
Shares |
|
|
Amount |
|
|
Number of
Shares |
|
|
Amount |
|
|
Paid in
Capital |
|
|
Accumulated
Deficit |
|
|
Stockholders’
Deficit |
|
|
|
Series A Convertible |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock |
|
|
Common Stock |
|
|
Additional |
|
|
|
|
|
Total |
|
|
|
Number of
Shares |
|
|
Amount |
|
|
Number of
Shares |
|
|
Amount |
|
|
Paid in
Capital |
|
|
Accumulated
Deficit |
|
|
Stockholders’
Deficit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - December 31,
2019 |
|
|
750,000 |
|
|
$ |
7,500 |
|
|
|
201,037,304 |
|
|
$ |
201,038 |
|
|
$ |
10,377,256 |
|
- |
$ |
(14,891,885 |
) |
|
$ |
(4,306,091 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
issued for services - third party |
|
|
- |
|
|
|
- |
|
|
|
2,021,006 |
|
|
|
2,021 |
|
|
|
70,899 |
|
|
|
- |
|
|
|
72,920 |
|
Convertible debt
converted into common stock |
|
|
- |
|
|
|
- |
|
|
|
70,264,956 |
|
|
|
70,265 |
|
|
|
(49,088 |
) |
|
|
- |
|
|
|
21,177 |
|
Derivative
liability |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
38,999 |
|
|
|
- |
|
|
|
38,999 |
|
Net
loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
- |
|
(1,733,953 |
) |
|
|
(1,733,953 |
) |
Balance - March 31, 2020 |
|
|
750,000 |
|
|
|
7,500 |
|
|
|
273,323,266 |
|
|
|
273,324 |
|
|
|
10,438,066 |
|
- |
|
(16,625,838 |
) |
|
|
(5,906,948 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible debt
converted into common stock |
|
|
- |
|
|
|
- |
|
|
|
1,270,440,600 |
|
|
|
1,270,440 |
|
|
|
(876,533 |
) |
|
|
- |
|
|
|
393,907 |
|
Derivative
liability |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,097,395 |
|
|
|
- |
|
|
|
2,097,395 |
|
Net
loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
- |
|
(48,243,951 |
) |
|
|
(48,243,951 |
) |
Balance - June 30, 2020 |
|
|
750,000 |
|
|
|
7,500 |
|
|
|
1,543,763,866 |
|
|
|
1,543,764 |
|
|
|
11,658,928 |
|
- |
|
(64,869,789 |
) |
|
|
(51,659,597 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible debt
converted into common stock |
|
|
- |
|
|
|
- |
|
|
|
517,493,337 |
|
|
|
517,493 |
|
|
|
225,526 |
|
|
|
- |
|
|
|
743,019 |
|
Derivative
liability |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,592,585 |
|
|
|
- |
|
|
|
1,592,585 |
|
Write off of due
to related party |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
100 |
|
|
|
- |
|
|
|
100 |
|
Net
income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
25,444,732 |
|
|
|
25,444,732 |
|
Net
income (Loss) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
- |
|
25,444,732 |
|
|
|
25,444,732 |
|
Balance -
September 30, 2020 |
|
|
750,000 |
|
|
$ |
7,500 |
|
|
|
2,061,257,203 |
|
|
$ |
2,061,257 |
|
|
$ |
13,477,139 |
|
- |
$ |
(39,425,057 |
) |
|
$ |
(23,879,161 |
) |
The
accompanying notes are an integral part of these unaudited
consolidated financial statements.
INDOOR
HARVEST CORP
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
The
accompanying notes are an integral part of these unaudited
consolidated financial statements.
INDOOR
HARVEST CORP
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES
Nature of Operations and
Organization
Indoor
Harvest Corp (the “Company,”) is a Texas corporation formed on
November 23, 2011. Our principal executive office was located at
7401 W. Slaughter Lane #5078, Austin, Texas 78739, and such
address is used in the interim. We are in the process of
establishing new offices.
On August
14, 2019, the Company established a wholly owned subsidiary, IHC
Consulting, Inc. (“IHC”), in the State of New York of the United
States of America. IHC Consulting will provide consulting and other
services to the Company and others on a contracted
basis.
COVID-19
A novel
strain of coronavirus (COVID-19) was first identified in December
2019, and subsequently declared a global pandemic by the World
Health Organization on March 11, 2020. As a result of the outbreak,
many companies have experienced disruptions in their operations and
in markets served. The Company has instituted some and may take
additional temporary precautionary measures intended to help ensure
the well-being of its managers and minimize business disruption.
The Company considered the impact of COVID-19 on the assumptions
and estimates used and determined that there were no material
adverse impacts on the Company’s results of operations and
financial position at September 30, 2020. The full extent of the
future impacts of COVID-19 on the Company’s operations is
uncertain. A prolonged outbreak could have a material adverse
impact on financial results and business operations of the Company,
including the timing and ability of the Company to develop its
business plan.
Interim Financial
Statements
The
accompanying unaudited financial statements have been prepared in
accordance with generally accepted accounting principles (GAAP)
applicable to interim financial information and the requirements of
Form 10-Q and Rule 8-03 of Regulation S-X of the Securities and
Exchange Commission. Accordingly, they may not include all of the
information and disclosure required by accounting principles
generally accepted in the United States of America for complete
financial statements. Interim results are not necessarily
indicative of results for a full year. In the opinion of
management, all adjustments considered necessary for a fair
presentation of the financial position and the results of
operations and cash flows for the interim periods have been
included. These interim financial statements should be read in
conjunction with the audited financial statements for the year
ended December 31, 2020, as not all disclosures required by
generally accepted accounting principles for annual financial
statements may be presented. The interim financial statements
follow the same accounting policies and methods of computations as
the audited financial statements for the year ended December 31,
2020.
Basis of
Presentation
The
accompanying condensed consolidated financial statements have been
prepared on the accrual basis of accounting in accordance with
accounting principles generally accepted in the United States of
America (“GAAP”) and the requirements of Form 10-Q and Rule 8-03 of
Regulation S-X of the U.S. Securities and Exchange Commission.
Accordingly, they may not include all of the information and
disclosures required by accounting principles generally accepted in
the United States of America for complete financial statements.
Interim results are not necessarily indicative of results for a
full year. In the opinion of management, all adjustments considered
necessary for a fair presentation of the financial position and the
results of operations and cash flows for the interim periods have
been included. These interim financial statements should be read in
conjunction with the audited financial statements for the year
ended December 31, 2020, as not all disclosures required by
generally accepted accounting principles for annual financial
statements may be presented.
Use of
Estimates
The
preparation of financial statements in conformity with GAAP
requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during
the reporting period. Actual results could differ from those
estimates.
Significant
estimates include, but are not limited to, the estimate of
percentage of completion on construction contracts in progress at
each reporting period which we rely on as a primary basis of
revenue recognition, estimated useful lives of equipment for
purposes of depreciation and the valuation of common shares issued
for services, equipment and the liquidation of
liabilities.
Principles of
Consolidation
The
consolidated financial statements include the accounts of the
Company and its wholly-owned subsidiary. All significant
inter-company accounts and transactions have been eliminated in
consolidation.
Earnings (Loss) per
Share
Basic
earnings (loss) per share amounts are calculated based on the
weighted average number of shares of common stock outstanding
during each period. Diluted earnings (loss) per share is based on
the weighted average numbers of shares of common stock outstanding
for the periods, including dilutive effects of stock options,
warrants granted and convertible preferred stock. Dilutive options
and warrants that are issued during a period or that expire or are
cancelled during a period are reflected in the computations for the
time they were outstanding during the periods being reported. Since
Indoor Harvest has incurred losses for all periods, the impact of
the common stock equivalents would be anti- dilutive and therefore
are not included in the calculation.
Derivative
Liability
The Company
accounts for derivative instruments in accordance with ASC 815,
which establishes accounting and reporting standards for derivative
instruments and hedging activities, including certain derivative
instruments embedded in other financial instruments or contracts
and requires recognition of all derivatives on the balance sheet at
fair value, regardless of hedging relationship designation.
Accounting for changes in fair value of the derivative instruments
depends on whether the derivatives qualify as hedge relationships
and the types of relationships designated are based on the
exposures hedged. At September 30, 2021 and December 31, 2020, the
Company did not have any derivative instruments that were
designated as hedges.
Fair Value of Financial
Instruments
As defined
in ASC 820” Fair Value Measurements,” fair value is the
price that would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants at
the measurement date (exit price). The Company utilizes market data
or assumptions that market participants would use in pricing the
asset or liability, including assumptions about risk and the risks
inherent in the inputs to the valuation technique. These inputs can
be readily observable, market corroborated, or generally
unobservable. The Company classifies fair value balances based on
the observability of those inputs. ASC 820 establishes a fair value
hierarchy that prioritizes the inputs used to measure fair value.
The hierarchy gives the highest priority to unadjusted quoted
prices in active markets for identical assets or liabilities (level
1 measurement) and the lowest priority to unobservable inputs
(level 3 measurement).
The
following table summarizes fair value measurements by level at
September 30, 2021 and December 31, 2020, measured at fair value on
a recurring basis:
SCHEDULE
OF FAIR VALUE OF ASSETS AND LIABILITIES MEASURED ON RECURRING
BASIS
September 30, 2021 |
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
None |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
420,313 |
|
|
$ |
420,313 |
|
December 31, 2020 |
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
None |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
44,274,727 |
|
|
$ |
44,274,727 |
|
Recently Issued Accounting
Pronouncements
In August
2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt—Debt
with “Conversion and Other Options” and ASC subtopic 815-40
“Hedging—Contracts in Entity’s Own Equity”. The standard reduced
the number of accounting models for convertible debt instruments
and convertible preferred stock. Convertible instruments that
continue to be subject to separation models are (1) those with
embedded conversion features that are not clearly and closely
related to the host contract, that meet the definition of a
derivative, and that do not qualify for a scope exception from
derivative accounting; and, (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as
paid-in capital. The amendments in this update are effective for
fiscal years beginning after December 15, 2021, including interim
periods within those fiscal years. Early adoption is permitted, but
no earlier than fiscal years beginning after December 15, 2020,
including interim periods within those fiscal years. The Company is
currently assessing the impact of the adoption of this standard on
its consolidated financial statements.
NOTE 2 - GOING
CONCERN
The
accompanying unaudited consolidated financial statements have been
prepared assuming that the Company will continue as a going
concern, which contemplates the realization of assets and the
liquidation of liabilities in the normal course of business. The
Company had minimal cash as of September 30, 2021, incurred losses
from its operations and did not generate cash from its operation
for past two years and the nine months ended September 30, 2021.
These factors, among others, raise substantial doubt about the
Company’s ability to continue as a going concern. The financial
statements do not include any adjustments that might result from
the outcome of this uncertainty.
The
Company’s continued existence is dependent upon management’s
ability to develop profitable operations, continued contributions
from the Company’s executive officers to finance its operations and
the ability to obtain additional funding sources to explore
potential strategic relationships and to provide capital and other
resources for the further development and marketing of the
Company’s products and business.
NOTE 3 – ACCOUNTS PAYABLE AND ACCRUED
LIABILITIES
Accounts
payable and accrued liabilities at September 30, 2021 and December
31, 2020 are as follows:
SCHEDULE
OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
|
|
September 30, |
|
|
December 31, |
|
|
|
2021 |
|
|
2020 |
|
Accounts payable |
|
$ |
248,649 |
|
|
$ |
283,357 |
|
Credit card |
|
|
13,645 |
|
|
|
16,570 |
|
Accrued expenses |
|
|
15,715 |
|
|
|
15,714 |
|
Accrued management fee |
|
|
3,183 |
|
|
|
3,605 |
|
Accrued
interest |
|
|
1,362 |
|
|
|
35,350 |
|
Accounts
payable and accrued liabilities |
|
$ |
282,554 |
|
|
$ |
354,596 |
|
NOTE 4 - CONVERTIBLE NOTES
PAYABLE
Convertible notes payable at
September 30, 2021 and December 31, 2020 are as
follows:
SCHEDULE
OF CONVERTIBLE NOTES PAYABLE
|
|
September 30, |
|
|
December 31, |
|
|
|
2021 |
|
|
2020 |
|
Note 1 |
|
$ |
- |
|
|
$ |
50,000 |
|
Note 2 |
|
|
- |
|
|
|
25,200 |
|
Note 3 |
|
|
- |
|
|
|
38,000 |
|
Note 4 - related party |
|
|
10,000 |
|
|
|
10,000 |
|
Note 5 |
|
|
25,000 |
|
|
|
- |
|
Total convertible notes payable |
|
|
35,000 |
|
|
|
123,200 |
|
|
|
|
|
|
|
|
|
|
Less:
Unamortized debt discount |
|
|
(10,556 |
) |
|
|
- |
|
Total convertible notes |
|
|
24,444 |
|
|
|
123,200 |
|
|
|
|
|
|
|
|
|
|
Less: current
portion of convertible notes |
|
|
24,444 |
|
|
|
123,200 |
|
Long-term
convertible notes |
|
$ |
- |
|
|
$ |
- |
|
During the
nine months ended September 30, 2021 and 2020, the Company recorded
interest expense of $31,720 and $492,162, and amortization of
discount of $14,444 and $111,685, respectively.
As of September 30, 2021 and December 31, 2020, the Company had
accrued interest of $1,362 and
$35,350,
respectively.
Repayment
The Company
had a dispute with Power Up, the holder of certain promissory notes
dated October 22, 2019, and December 19, 2019, issued by the
Registrant, including allegations or claims of default and a suit.
As part of the Company’s recovery efforts after COVID-19, it
reached an amicable resolution with “Power Up”, in third quarter of
2021, whereby the Company and Power Up agreed on an amount of
$80,000 to settlement this dispute
in its entirety. During nine months ended September 30, 2021, the
Company repaid $80,000 to Power Up for Note 2 and 3
and accrued interest. As a result, the Company recorded loss on
settlement of debt of $4,987.
Note 1
On October
12, 2017, the Company issued a fixed convertible promissory note to
Tangiers for the principal sum of $50,000 as a commitment fee for the
Investment Agreement. The promissory note (“Note 1”) maturity date
is May 12, 2018. The principal
amount due under Note 1 can be converted by Tangiers any time, into
shares of the Company’s common stock at a conversion price of
$0.1666 per
share. The promissory note is in a “Maturity Default,” which is
defined in Note 1 as the event in which Note 1 is not retired prior
to its maturity date, Tangiers’ conversion rights under Note 1
would be adjusted such that the conversion price would be the lower
of (i) $0.1666 or (ii) b) 65% of the average of
the two lowest trading prices of the Company’s common stock during
the 10 consecutive
trading days prior to the date on which Tangiers elects to convert
all or part of the note. The default interest rate is 20%. During nine months ended
September 30, 2021, the note was fully forgiven and the Company
recorded gain on settlement of debt of $89,451.
Note 2
On October
22, 2019, the Company issued and sold an 10% Fixed Convertible Promissory
Note (“Note 2”) to Power Up Lending Group Ltd. (“Power Up”), in the
principal amount of $48,000, which includes a $3,000 original issue
discount. Note 2 is convertible into shares of the Company’s common
stock one hundred eighty (180) days from October 22, 2019. Note 2
is convertible at a conversion price of 61% of the average of
the two (2) lowest trading prices of the Company’s common stock
during the twenty (20)
consecutive trading days prior to the date of on which Power Up
elects to convert all or part of the Note 2.
Note 3
On December
19, 2019, the Company issued and sold an 10% Fixed Convertible Promissory
Note (“Note 3”) to Power Up Lending Group Ltd. (“Power Up”), in the
principal amount of $38,000, which includes a $3,000 original issue
discount. Note 3 is convertible into shares of the Company’s common
stock one hundred eighty (180) days from December 22, 2019. Note 3
is convertible at a conversion price of 61% of the average of
the two (2) lowest trading prices of the Company’s common stock
during the twenty (20)
consecutive trading days prior to the date of on which Power Up
elects to convert all or part of the Note 3.
Note 4 – related
party
On September
28, 2020, the Company issued and sold an 10% Fixed Convertible Promissory
Note (“Note 4”) to a related party, in the principal amount of
$10,000. Note 4 is convertible into
shares of the Company’s common stock ninety (90) days from
September 28, 2020. Note 4 is convertible at the lower conversion
price of $0.002 or
65% of the lowest
trading prices of the Company’s common stock during the fifteen
(15)
consecutive trading days prior to the date of on which a noteholder
elects to convert all or part of the Note 4. The note is currently
in default.
Note 5
In March
2021, a third party advanced $25,000 to assist the
Company in operating expenses and the Company is in the process of
confirming arrangements for the repayment of said amount. The
advance has non-interest bearing.
On August 9,
2021, the Company issued and sold an 10% Fixed Convertible
Promissory Note (“Note 5”), in the principal amount of $25,000. Note 5 is convertible into
shares of the Company’s common stock sixty (60) days from August 9,
2021. Note 5 is convertible at the lower conversion price of
$0.00225 or
65% of the lowest
trading prices of the Company’s common stock during the fifteen
(15)
consecutive trading days prior to the date of on which a noteholder
elects to convert all or part of the Note 5.
NOTE 5 - DERIVATIVE
LIABILITIES
The Company
identified the conversion features embedded within its convertible
debts as financial derivatives. The Company has determined that the
embedded conversion option should be accounted for at fair
value.
At September
30, 2021, the estimated fair values of the liabilities measured on
a recurring basis are as follows:
SCHEDULE OF ESTIMATED
FAIR VALUE OF LIABILITIES MEASURED ON RECURRING
BASIS
|
|
Nine months ended |
|
|
|
September
30, 2021 |
|
Expected term |
|
|
0.10 - 0.25 |
|
Expected average volatility |
|
|
165% -
191 |
% |
Expected dividend yield |
|
|
- |
|
Risk-free interest
rate |
|
|
0.07 |
% |
The
following schedule shows the change in fair value of the derivative
liabilities at September 30, 2021:
SCHEDULE
OF CHANGE IN FAIR VALUE OF DERIVATIVE LIABILITIES
Fair Value
Measurements Using Significant Observable Inputs (Level 3) |
Balance - December 31,
2020 |
|
$ |
44,274,727 |
|
Addition of new derivatives recognized
as debt discounts |
|
|
25,000 |
|
Addition of new derivatives recognized
as loss on derivatives |
|
|
96,923 |
|
Loss on change
in fair value of the derivative |
|
|
(43,976,337 |
) |
Balance -
September 30, 2021 |
|
$ |
420,313 |
|
The
aggregate (gain) loss on derivatives during the nine months ended
September 30, 2021 and 2020 was ($43,976,337) and
$23,849,072,
respectively. The Company values these derivative liabilities using
Black-Scholes model or flexible the pricing models that include
quantitative input such as the risk free rate, market volatility,
time to maturity, conversion price, and other qualitative factors
such as whether the underlying indexed security is in good standing
or in default.
NOTE 6 - SHAREHOLDERS’
EQUITY
Series A Convertible Preferred
Stock
As of
September 30, 2021 and December 31, 2020, there were 750,000
shares of Series A Convertible Preferred Stock issued and
outstanding.
On August
27, 2021, the Company completed an initiative where it entered into
a Modification Agreement (the “Modification”) with current Series A
Convertible Preferred Stockholders to modify their conversion
privileges to align and support the current management team’s
initiatives with the goal of benefiting shareholders. The
modification agreement provides the preferred stockholders the
right to convert their preferred shares into common shares at a
conversion price at the lower of $0.40 (per the
original agreement), or the subsequent per share pricing of a
future equity raise greater than Five Hundred Thousand ($500,000)
Dollars. This Modification was pursued for the benefit of the
Company’s common shareholders to mitigate the potential risk of
diluting their shareholding in the event that the Company
undertakes additional financing transactions to fund the Company’s
expansion initiatives.
Common Stock
During the
nine months ended September 30, 2021, there were no share
issuances.
On August
26, 2021, the Company entered into subscription agreements, with
certain accredited investors for the sale of 82,000,000 shares of
the Company’s common stock, par value of $0.001 per share, for a total
consideration to the Company of $410,000.
As of
September 30, 2021 and December 31, 2020, there were 2,483,396,041 and
2,401,396,041
shares of Common Stock issued and outstanding.
Additional paid in
capital
During the
nine months ended September 30, 2021, the amount due to related
party of $52
was forgiven and the Company recorded additional paid in
capital.
Stock Options
On August 4,
2021, the Board has recognized the substantive efforts of Messrs.
Leslie Bocskor, Benjamin Rote, and Dennis Forchic to sustain and
support the Company over the past year without compensation while
laying the foundation for the future. The Board has voted to
formalize employment agreements with Messrs. Bocskor and Rote, and
an advisory agreement with Mr. Forchic. Stock option agreements
reflecting past contributions and incentives for the future have
been issued to all three parties. Stock options plans were offered
with an exercise price of $0.01
and
consideration of
150 million options to Mr.
Bocskor,
100 million options to Mr.
Rote, and
150 million options to Mr.
Forchic vesting immediately. On the 1-year anniversary of their
respective agreements, additional stock options priced at
$0.015
will vest
with consideration of
150 million options to Mr.
Bocskor,
100 million options to Mr.
Rote, and
150 million options to Mr.
Forchic.
In addition,
the Board, consisting of Directors Rick Gutshall and Lang Coleman,
having not received any consideration over the past 2 years, will
receive stock options of 5 million options each
at a price of $0.01 vesting
immediately. The company’s legal counsel will be receiving
10 million options at a
price of $0.01 vesting
immediately, under the same terms as the Board, in recognition of
their valuable work and support.
Valuation
The Company
utilizes the Black-Scholes model to value its stock options. The
Company utilized the following assumptions:
SCHEDULE OF UTILIZES THE BLACK-SCHOLES MODEL
TO VALUES TO STOCK OPTIONS ASSUMPTIONS
|
|
Nine months ended |
|
|
|
September
30, 2021 |
|
Expected term |
|
|
5.00 - 5.50 years |
|
Expected average volatility |
|
|
198 - 203 |
% |
Expected dividend yield |
|
|
- |
|
Risk-free interest
rate |
|
|
0.67 |
% |
During the
nine months ended September 30, 2021, the Company granted 820,000,000 options
valued at $8,004,855. During the nine
months ended September 30, 2021, the Company recognized stock
option expense of $4,753,205, of which $4,655,518 was to related
parties, and as of September 30, 2021, $2,763,902
remains unamortized, of which $2,763,902 is with related
parties. The intrinsic value of the 820,000,000
options outstanding as of September 30, 2021 is $9,398,000.
The
following is a summary of stock option activity during the nine
months ended September 30, 2021:
SCHEDULE
OF STOCK OPTION
|
|
Options
Outstanding |
|
|
Weighted |
|
|
|
Number of |
|
|
Weighted
Average |
|
|
Average
Remaining life |
|
|
|
Options |
|
|
Exercise
Price |
|
|
(years) |
|
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2020 |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Granted |
|
|
820,000,000 |
|
|
|
0.01 |
|
|
|
10.00 |
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited/canceled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Outstanding, September 30, 2021 |
|
|
820,000,000 |
|
|
$ |
0.01 |
|
|
|
9.85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable options, September
30, 2021 |
|
|
420,000,000 |
|
|
$ |
0.01 |
|
|
|
9.85 |
|
NOTE 7 - NET INCOME (LOSS) PER COMMON
SHARE
Basic net
income per common share is computed by dividing net income by the
weighted average number of common shares outstanding during the
periods. Diluted net income per common share is computed using the
weighted average number of common and dilutive common equivalent
shares outstanding during the periods. Common equivalent shares
consist of convertible preferred stock and convertible notes that
are computed using the if-converted method, and outstanding
warrants that are computed using the treasury stock method.
Antidilutive stock awards consist of stock options that would have
been antidilutive in the application of the treasury stock
method.
SCHEDULE
OF EARNINGS PER SHARE, BASIC AND DILUTED
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September
30, |
|
|
September
30, |
|
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
116,422,813 |
|
|
$ |
25,444,732 |
|
|
$ |
39,052,316 |
|
|
$ |
(24,533,172 |
) |
(Gain) on change in fair value of
derivatives |
|
|
(121,194,219 |
) |
|
|
(25,835,130 |
) |
|
|
(43,879,414 |
) |
|
|
- |
|
Interest on
convertible debt |
|
|
608 |
|
|
|
329,453 |
|
|
|
1,104 |
|
|
|
- |
|
Net income
(loss) - diluted |
|
$ |
(4,770,798 |
) |
|
$ |
(60,945 |
) |
|
$ |
(4,825,994 |
) |
|
$ |
(24,533,172 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
2,433,482,998 |
|
|
|
818,037,754 |
|
|
|
2,412,209,228 |
|
|
|
513,135,724 |
|
Effect of dilutive shares |
|
|
207,748,451 |
|
|
|
12,939,919,067 |
|
|
|
643,116,261 |
|
|
|
- |
|
Diluted |
|
|
2,641,231,449 |
|
|
|
13,757,956,821 |
|
|
|
3,055,325,489 |
|
|
|
513,135,724 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common
share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.05 |
|
|
$ |
0.03 |
|
|
$ |
0.02 |
|
|
$ |
(0.05 |
) |
Diluted |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
(0.05 |
) |
For the nine
months ended September 30, 2020, the convertible instruments are
anti-dilutive and therefore, have been excluded from earnings
(loss) per share.
NOTE 8 - SUBSEQUENT
EVENTS
The Company
evaluates subsequent events that have occurred after the balance
sheet date of September 30, 2021, and up through November 15, 2021,
which is the date that these financial statements are available to
be issued. There are two types of subsequent events: (i)
recognized, or those that provide additional evidence with respect
to conditions that existed at the date of the balance sheet,
including the estimates inherent in the process of preparing
financial statements, and (ii) non-recognized, or those that
provide evidence with respect to conditions that did not exist at
the date of the balance sheet but arose subsequent to that
date.
On October
1, the Company converted the Electrum Partners outstanding
Convertible Promissory Note of $10,000
issued September 28, 2021 into
5,125,000 restricted common shares
of the Company.
On November
8, 2021, the Company finalized a Supplemental agreement with the
Series A Preferred shareholders to convert their holdings into
common shares of the Company at $0.0125
in alignment
and support of the current management team’s initiatives with the
goal of benefiting shareholders. This agreement was pursued for the
benefit of the Company’s common shareholders to mitigate the
potential risk of diluting their shareholding in the event that the
Company undertakes additional financing transactions to fund the
Company’s expansion initiatives.
Pursuant to the Preferred Shareholder’s Supplemental Agreement
dated November 8, 2021 (the “Supplemental Agreement”) by and
between the Company and holders of its Series A Preferred shares,
under which holders of the Series A Preferred shares agreed to
convert all of the Series A Preferred shares into common shares of
the Company effective November 8, 2021, the Company has issued an
aggregate of sixty (60) million restricted common shares. The
restricted common shares issued are subject to Rule 144 required
holding periods.
On November
8, 2021, the Company entered into subscription agreements with
certain accredited investors for the sale of Sixteen Million
(16,000,000) common
shares of the Company, par value of $0.001 per share, for a total
consideration to the Company of Two Hundred Thousand ($200,000) Dollars. The
issued shares will be restricted under Rule 144 required holding
periods. The Company intends to use the net proceeds from the sale
for general corporate purposes and working capital.
On November
9, the Company converted the $25,000 10% Fixed
Convertible Promissory Note, including interest, issued on
August 9, 2021 into
11,388,889 common shares. The issued shares will be
restricted under Rule 144 required holding periods.
Item
2. |
Management’s
Discussion and Analysis of Financial Condition and Results of
Operation |
Results of
Operations
The
following tables presents our operating results for the three and
nine months ended September 30, 2021 compared to September 30,
2020:
Three
months ended September 30, 2021 compared to three months ended
September 30, 2020
|
|
Three Months Ended |
|
|
|
|
|
|
|
|
|
September
30, |
|
|
|
|
|
|
|
|
|
2021 |
|
|
2020 |
|
|
Change |
|
|
% |
|
Revenue |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
|
- |
|
Operating
expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
expense |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
Professional fees |
|
|
130,982 |
|
|
|
19,987 |
|
|
|
110,995 |
|
|
|
555 |
% |
General and
administrative expenses |
|
|
4,696,798 |
|
|
|
69 |
|
|
|
4,696,729 |
|
|
|
6806854 |
% |
Total operating
expenses |
|
|
4,827,780 |
|
|
|
20,056 |
|
|
|
4,807,724 |
|
|
|
23972 |
% |
Loss from
operations |
|
|
(4,827,780 |
) |
|
|
(20,056 |
) |
|
|
(4,807,724 |
) |
|
|
23972 |
% |
Other expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) |
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
|
|
Interest income (expense) |
|
|
(28,090 |
) |
|
|
(370,342 |
) |
|
|
342,252 |
|
|
|
92 |
% |
Amortization of debt discount |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair
value of embedded derivative liability |
|
|
121,194,219 |
|
|
|
25,835,130 |
|
|
|
95,359,089
|
|
|
|
369 |
% |
Gain on
settlement of debt |
|
|
84,464 |
|
|
|
- |
|
|
|
84,464 |
|
|
|
|
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
other income (expense) |
|
|
121,250,593 |
|
|
|
25,464,788 |
|
|
|
95,785,805
|
|
|
|
376 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss |
|
$ |
116,422,813 |
|
|
$ |
25,444,732 |
|
|
$ |
90,978,081
|
|
|
|
358
|
% |
Nine
months ended September 30, 2021 compared to nine months ended
September 30, 2020
|
|
Nine Months Ended |
|
|
|
|
|
|
|
|
|
September
30, |
|
|
|
|
|
|
|
|
|
2021 |
|
|
2020 |
|
|
Change |
|
|
% |
|
Revenue |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
|
- |
|
Operating
expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and
amortization expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Professional fees |
|
|
172,139 |
|
|
|
181,649 |
|
|
|
(9,510 |
) |
|
|
5 |
% |
General and administrative expenses |
|
|
4,707,703 |
|
|
|
10,289 |
|
|
|
4,767,414 |
|
|
|
46335 |
% |
Total
operating expenses |
|
|
4,879,842 |
|
|
|
191,938 |
|
|
|
4,687,904 |
|
|
|
2479 |
% |
Loss from
operations |
|
|
(4,879,842 |
) |
|
|
(191,938 |
) |
|
|
(4,687,904 |
) |
|
|
2479 |
% |
Other expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense |
|
|
(31,720 |
) |
|
|
(492,162 |
) |
|
|
460,442 |
|
|
|
(94 |
)% |
Amortization of
debt discount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of embedded derivative liability |
|
|
43,879,414 |
|
|
|
(23,849,072 |
) |
|
|
67,728,486 |
|
|
|
(284 |
)% |
Gain
on settlement of debt |
|
|
84,464 |
|
|
|
- |
|
|
|
84,464 |
|
|
|
100 |
% |
Total other income (expense) |
|
|
43,932,158 |
|
|
|
(24,341,234 |
) |
|
|
(68,188,928 |
) |
|
|
280 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss |
|
$ |
39,052,316 |
|
|
$ |
(24,533,172 |
) |
|
$ |
63,585,488 |
|
|
|
259 |
% |
Revenues
During the
nine months ended September 30, 2021 and 2020, the Company
generated no revenue.
Operating
Expenses
Total
operating expenses for the nine months ended September 30, 2021 and
2020 were $4,879,842 and $191,938, respectively, for an aggregate
increase of $4,687,904 or 2442%. The aggregate increase was
primarily driven by an increase in general and administrative
expenses of $4,707,703 or 46335% associated with executive stock
options compensation.
Other Income
(Expense)
Total other income (expense) for the nine months ended September
30, 2021 and 2020 were $43,932,158 and ($24,341,234), respectively.
The decrease in other expense is primarily related to the change in
the fair value of the embedded derivative liability from
($23,849,072) to $43,879,414 .
Net Loss
As a result of the factors discussed above, net income for the nine
months ended September 30, 2021 and 2020 was $39,052,316 and
($24,533,172), respectively, for an increase of $63,585,488 or
259%.
Liquidity
and Capital Resources
The
following table provides selected financial data about our Company
as of September 30, 2021 and December 31, 2020,
respectively.
Working Capital
|
|
September 30,
2021
|
|
|
December 31,
2020
|
|
|
Change |
|
|
% |
|
Current assets |
|
$ |
193,444 |
|
|
$ |
3,083 |
|
|
$ |
190,361 |
|
|
|
6,175 |
% |
Current
liabilities |
|
$ |
727,311 |
|
|
$ |
44,752,523 |
|
|
$ |
(44,025,212 |
) |
|
|
(98 |
)% |
Working capital
deficiency |
|
$ |
(533,867 |
) |
|
$ |
(44,749,440 |
) |
|
$ |
(44,215.573 |
) |
|
|
(99 |
)% |
Cash Flows
|
|
Nine Months Ended |
|
|
|
|
|
|
|
|
|
September
30, 2021 |
|
|
|
|
|
|
|
|
|
2021 |
|
|
2020 |
|
|
Change |
|
|
% |
|
Cash used in operating
activities |
|
$ |
(181,783 |
) |
|
$ |
(18,335 |
) |
|
$ |
(163,448 |
) |
|
|
891 |
% |
Cash provided by financing
activities |
|
$ |
371,800 |
|
|
$ |
7,240 |
|
|
$ |
364,560 |
) |
|
|
5035 |
% |
Net Change in Cash During Period |
|
$ |
190,017 |
|
|
$ |
(11,095 |
) |
|
$ |
201,112 |
|
|
|
(1813 |
)% |
As of
September 30, 2021, our Company’s cash balance was $191,224 and
total assets were $193,444. As of December 31, 2020, our Company’s
cash balance was $1,207 and total assets were $3,083.
As of
September 30, 2021, our Company had total liabilities of $727,311
compared with total liabilities of $44,752,523 as at December 31,
2020.
As of
September 30, 2021, our Company had a working capital deficiency of
$533,867 compared with a working capital deficiency of $44,749,440
as of December 31, 2020. The decrease in working capital deficiency
was primarily attributed to a decrease in derivative
liabilities.
Cash Flow
from Operating Activities
Net cash
used in operating activities for the nine months ended September
30, 2021 and 2020 were $181,783 and $18,335 respectively, for an
increase of $163,448. The increase in net cash used in operating
activities is primarily related to retirement of outstanding debt,
payments on accounts payables and accrued liabilities, and payment
for vendor services
Cash Flow
from Investing Activities
For the nine
months ended September 30, 2021 and 2020, our Company did not have
any investing activities.
Cash Flow
from Financing Activities
Net cash
provided by (used in) financing activities for the nine months
ended September 30, 2021 and 2020 were $371,800 and $7,240,
respectively. During the nine months ended September 30, 2021, our
Company repaid convertible notes of $63,200.
Item
3. |
Quantitative and
Qualitative Disclosures About Market Risk |
As a
“smaller reporting company”, we are not required to provide the
information required by this Item.
Item
4. |
Controls
and Procedures |
Evaluation of
Disclosure Controls and Procedures
The Company
maintains disclosure controls and procedures (as defined in Rule
13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934
(the “Exchange Act”)) that are designed to ensure that information
required to be disclosed in the Company’s Exchange Act reports is
recorded, processed, summarized and reported within the time
periods specified in SEC rules and forms, and that such information
is accumulated and communicated to the Company’s management,
including its Chief Executive Officer, Chief Financial Officer, as
appropriate, to allow timely decisions regarding required
disclosure.
In designing
and evaluating the disclosure controls and procedures, management
recognizes that any controls and procedures, no matter how well
designed and operated, can provide only reasonable assurance of
achieving the desired control objectives, and management is
required to apply its judgment in evaluating the cost-benefit
relationship of possible controls and procedures.
The
Company’s management, consisting solely of the Company’s Chief
Executive Officer, Chief Financial Officer, has evaluated the
effectiveness of the Company’s disclosure controls and procedures
as of the end of the period covered by this report. Based upon that
evaluation, the Chief Executive Officer and Chief Financial Officer
has concluded that, as of September 30, 2020, the Company’s
disclosure controls and procedures were not effective because of
the following internal control over financial reporting
deficiencies:
● We
currently have an insufficient complement of personnel with the
necessary accounting expertise and an inadequate supervisory review
structure with respect to the requirements and application of US
GAAP and SEC disclosure requirements.
● We
currently have insufficient written policies and procedures for
accounting and financial reporting with respect to the requirements
and application of US GAAP and SEC disclosure
requirements.
● We
currently lack a formal process and timeline for closing the books
and records at the end of each reporting period and such weaknesses
restrict the Company’s ability to timely gather, analyze and report
information relative to the financial statements.
● Our
Company’s management is composed of a small number of individuals
resulting in a situation where limitations on segregation of duties
exist.
We will
continue to monitor and evaluate the effectiveness of our
disclosure controls and procedures and our internal controls over
financial reporting on an ongoing basis and are committed to taking
further action and implementing additional enhancements or
improvements, as necessary and as funds allow.
Changes in
Internal Controls
There have
been no changes in our internal controls over financial reporting
identified in connection with the evaluation required by paragraph
(d) of Securities Exchange Act Rule 13a-15 or Rule 15d-15 that
occurred in the quarter ended September 30, 2021 that have
materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting.
PART II - OTHER
INFORMATION
Item
1. |
Legal
Proceedings |
From time to
time we may become involved in various legal proceedings that arise
in the ordinary course of business. We are not currently a party to
any material legal proceeding.
As a
“smaller reporting company”, we are not required to provide the
information required by this Item.
Item
2. |
Unregistered Sales of
Equity Securities and Use of Proceeds |
None.
Item
3. |
Defaults
Upon Senior Securities |
None.
Item
4. |
Mine
Safety Disclosures |
Not
Applicable.
Item
5. |
Other
Information |
(a) Not
applicable.
(b) Not
applicable.
The
following exhibits are included as part of this report:
* Filed
herewith. In addition, in accordance with SEC Release 33-8238,
Exhibits 32.1 and 32.2 are being furnished and not
filed.
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
INDOOR
HARVEST CORP. |
|
(Registrant) |
|
|
Dated:
November 15, 2021 |
/s/
Leslie Bocskor |
|
Leslie
Bocskor |
|
Chief Executive Officer,
Chief Financial Officer |
|
(Principal Executive
Officer)(Principal Financial Officer) |
Indoor Harvest (PK) (USOTC:INQD)
Historical Stock Chart
From Apr 2022 to May 2022
Indoor Harvest (PK) (USOTC:INQD)
Historical Stock Chart
From May 2021 to May 2022